LAM Treatment Alliance Fast Tracking Treatment Research

Priority Projects, Clinical Studies and Trials

Below are some of the current priority projects:

Biomarker Development

Innovative Trial Design
Drug Target Prioritization
Drug Target Validation: Disease Model and Cell Line Development; identification of Cell of Origin
Target Identification (approved drug screens)

Clinical Trials

NOTE: if you are a patient looking to participate in a clinical trial, please visit http://www.cancer.gov/clinicaltrials/learning first.

Trial Name

Visit http://clinicaltrials.gov/ct2/results?term=lam&cond=%22Lymphangioleiomyomatosis%22 for details on trials dealing with LAM.

LAM Treatment Alliance

E-mail: info@lamtreatmentalliance.org

Address: 64 Church Street, 2nd floor; Cambridge, MA 02138; USA

Phone: +1 (617) 460-7339

Fax: +1 (617) 864-0614


Sponsors, Partners and Supporters